Details for New Drug Application (NDA): 208419
✉ Email this page to a colleague
The generic ingredient in PEMETREXED is pemetrexed ditromethamine. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pemetrexed ditromethamine profile page.
Summary for 208419
Tradename: | PEMETREXED |
Applicant: | Actavis |
Ingredient: | pemetrexed |
Patents: | 0 |
Pharmacology for NDA: 208419
Mechanism of Action | Folic Acid Metabolism Inhibitors |
Suppliers and Packaging for NDA: 208419
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PEMETREXED | pemetrexed | SOLUTION;INTRAVENOUS | 208419 | NDA | Teva Pharmaceuticals, Inc. | 0480-4514 | 0480-4514-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0480-4514-01) / 20 mL in 1 VIAL, SINGLE-DOSE |
PEMETREXED | pemetrexed | SOLUTION;INTRAVENOUS | 208419 | NDA | Teva Pharmaceuticals, Inc. | 0480-4515 | 0480-4515-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0480-4515-01) / 40 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 100MG/4ML (25MG/ML) | ||||
Approval Date: | Aug 21, 2020 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 500MG/20ML (25MG/ML) | ||||
Approval Date: | Aug 21, 2020 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 1GM/40ML (25MG/ML) | ||||
Approval Date: | Aug 21, 2020 | TE: | RLD: | Yes |
Complete Access Available with Subscription